Recurrent Gynecological
1 clinical trials · Condition
◉ Watch Recurrent Gynecological
| Record | Firm | Date |
|---|---|---|
| Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA) (NCT04699071) | National University Hospital, Singapore | 2021-02-18 |
Track Recurrent Gynecological automatically
Every clearance here is in the API, with alerts when new ones post.